Stark Medical Resorts Inc☆Watch⊞Compare

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Stark Medical Resorts Inc is one of 2138 Healthtech companies tracked from SHERIDAN. By capital raised it ranks among the largest (ahead of 99% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

SMR Stark Medical Resorts

Nestled on the pristine shores of Abaco, Treasure Cay Integrated Medical Campus (TCIMC) offers cutting-edge regenerative therapies in the Bahamas’ serene environment. Restore your vitality at a fraction of U.S. costs while your spirit soars amidst endless azure horizons. Pioneering stem cell & longevity protocols under the 2024 Regenerative Therapies Bill 5+ acres of bespoke healing suites & villas in a $1.5B eco-luxury enclave 5+ acres of bespoke healing suites & villas in a $1.5B eco-luxury enclave Imagine emerging from therapy not just healed, but transformed—your body renewed by adipose-derived stem cells, your days filled with yacht-side yoga and reef-kissed recovery. At TCIMC, we craft bespoke journeys where medical precision dances with island alchemy, turning recovery into revelation. Where Healing Feels Different and Recovery Becomes an Experience Stark Medical Resorts ignites a new dawn for Bahamian healing at Treasure Cay. Born from a visionary land acquisition in GreenPointe’s $1.5B masterplan, TCIMC rises as the archipelago’s beacon for regenerative renaissance—where chronic challenges yield to cellular triumphs, and every breath whispers renewal. Since securing our di

Trades publicly as SMR Stark Medical Resorts.

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Round size and date are reported; the stage label is inferred from round size (latest is Growth/Late — a round over $400M). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 99% of sector peers (real $). Modeled value above 100% of peers (estimate).

A tighter cohort than the sector chart above — only companies at the same stage (Growth/Late) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

1. Series D+$260.0M2023-07-11
   • First recorded raise — entered as Series D+.
2. Growth/Late$465.0M2024-02-08
   • Came back fast: 7 mo vs the ~14 mo sector norm.
   • Round 1.8× larger than the prior — scaling up.
   • Switched to Rule 506(c) (was Rule 506(b)).
3. Growth/Late$365.0M2024-04-15
   • Came back fast: 2 mo vs the ~14 mo sector norm.
   • Round roughly the size of the prior one.
   • Switched to Rule 506(b) (was Rule 506(c)).

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

Stark Medical Resorts Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where Stark Medical Resorts Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at Stark Medical Resorts Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.